rilpivirine

North America

Canada (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT 25MG tabs
Rx
oral
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT 25MG tabs
02370603
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

United States (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT EQ 25MG BASE tabs
Y
Rx
oral
J05AG05
RILPIVIRINE 25MG tabs
Y
oral
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT EQ 25MG BASE tabs
202022/1
NDA
20-05-2011
RILPIVIRINE 25MG tabs
205302/1
ANDA
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Europe

Austria (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT 25 MG fc tabs
Rx
-
J05AG05
REKAMBYS 600 MG DEPOT- susp for inj
Rx
-
J05AG05
REKAMBYS 900 MG DEPOT- susp for inj
Rx
-
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT 25 MG fc tabs
EU/1/11/736/001
28-11-2011
REKAMBYS 600 MG DEPOT- susp for inj
EU/1/20/1482/001
17-12-2020
REKAMBYS 900 MG DEPOT- susp for inj
EU/1/20/1482/002
17-12-2020
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Belgium (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT 25 MG fc tabs
30x
Y
oral
J05AG05
REKAMBYS 600 MG pr susp for inj
1x, 2 mL
-
im
J05AG05
REKAMBYS 900 MG pr susp for inj
1x, 3 mL
-
im
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT 25 MG fc tabs
30x
EU/1/11/736/001
CP
REKAMBYS 600 MG pr susp for inj
1x, 2 mL
EU/1/20/1482/001
CP
REKAMBYS 900 MG pr susp for inj
1x, 3 mL
EU/1/20/1482/002
CP
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
EDURANT 25 MG fc tabs
30x
227,15
REKAMBYS 600 MG pr susp for inj
1x, 2 mL
REKAMBYS 900 MG pr susp for inj
1x, 3 mL
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Bosnia and Herzegovina (0)
No result.
Croatia (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT -
-
Rx
-
J05AG05
REKAMBYS -
-
Rx
-
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT -
REKAMBYS -
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Czechia (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT 25MG fc tabs
25MG 30
Y
oral
J05AG05
REKAMBYS 600MG pr susp for inj
600MG 1+STŘ+AD+1J
N
im
J05AG05
REKAMBYS 900MG pr susp for inj
900MG 1+STŘ+AD+1J
N
im
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT 25MG fc tabs
25MG 30
EU/1/11/736/001
CP
REKAMBYS 600MG pr susp for inj
600MG 1+STŘ+AD+1J
EU/1/20/1482/001
CP
REKAMBYS 900MG pr susp for inj
900MG 1+STŘ+AD+1J
EU/1/20/1482/002
CP
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
EDURANT 25MG fc tabs
25MG 30
5893,57
7466,04
REKAMBYS 600MG pr susp for inj
600MG 1+STŘ+AD+1J
0
REKAMBYS 900MG pr susp for inj
900MG 1+STŘ+AD+1J
0
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Denmark (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT 25 MG fc tabs
-
-
J05AG05
REKAMBYS 600 MG pr susp for inj
-
-
J05AG05
REKAMBYS 900 MG pr susp for inj
-
-
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT 25 MG fc tabs
28104759610
CP
28-11-2011
REKAMBYS 600 MG pr susp for inj
28106311319
CP
04-02-2021
REKAMBYS 900 MG pr susp for inj
28106581719
CP
04-02-2021
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
EDURANT 25 MG fc tabs
REKAMBYS 600 MG pr susp for inj
REKAMBYS 900 MG pr susp for inj
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Finland (4)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT 25 MG fc tabs
30x in tablet container
Y
Rx
-
J05AG05
EDURANT 25 MG fc tabs
30x in tablet container
Y
Rx
-
J05AG05
REKAMBYS 600 MG pr susp for inj
1 x 2 ml in vial
N
Rx
-
J05AG05
REKAMBYS 900 MG pr susp for inj
3 ml in vial
Y
Rx
-
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT 25 MG fc tabs
30x in tablet container
-
28-11-2011
EDURANT 25 MG fc tabs
30x in tablet container
PI
26-06-2019
REKAMBYS 600 MG pr susp for inj
1 x 2 ml in vial
-
17-12-2020
REKAMBYS 900 MG pr susp for inj
3 ml in vial
-
17-12-2020
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Hungary (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT 25 MG fc tabs
30x hdpe container
Y
Rx
oral
J05AG05
REKAMBYS 600 MG RETARD susp for inj
1x2ml vial +1 syringe +1 inj glass adapt
N
Rx
-
J05AG05
REKAMBYS 900 MG RETARD susp for inj
1x3ml vial +1 syringe +1 inj glass adapt
N
Rx
-
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT 25 MG fc tabs
30x hdpe container
EU/1/11/736/001
28-11-2011
REKAMBYS 600 MG RETARD susp for inj
1x2ml vial +1 syringe +1 inj glass adapt
EU/1/20/1482/001
17-12-2020
REKAMBYS 900 MG RETARD susp for inj
1x3ml vial +1 syringe +1 inj glass adapt
EU/1/20/1482/002
17-12-2020
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
EDURANT 25 MG fc tabs
30x hdpe container
63400
66189,6
67180
70539
REKAMBYS 600 MG RETARD susp for inj
1x2ml vial +1 syringe +1 inj glass adapt
0
0
0
0
REKAMBYS 900 MG RETARD susp for inj
1x3ml vial +1 syringe +1 inj glass adapt
0
0
0
0
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Iceland (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT 25 MG fc tabs
Y
Rx
-
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT 25 MG fc tabs
28-11-2011
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
EDURANT 25 MG fc tabs
40.887
40.887
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Ireland (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT 25 MG fc tabs
-
Rx
oral
J05AG05
REKAMBYS 600 MG pr susp for inj
-
Rx
im
J05AG05
REKAMBYS 900 MG pr susp for inj
-
Rx
-
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT 25 MG fc tabs
EU/1/11/736/001
28-11-2011
REKAMBYS 600 MG pr susp for inj
EU/1/20/1482/001
17-12-2020
REKAMBYS 900 MG pr susp for inj
EU/1/20/1482/002
17-12-2020
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Lithuania (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT 25 MG fc tabs
N30 bottle
Rx
oral
J05AG05
REKAMBYS 600 MG pr susp for inj
N1 (flakono adapteris, švirkštas ir inje
Rx
im
J05AG05
REKAMBYS 900 MG pr susp for inj
N1 (flakono adapteris, švirkštas ir inje
Rx
im
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT 25 MG fc tabs
N30 bottle
EU/1/11/736/001
CP
28-11-2011
REKAMBYS 600 MG pr susp for inj
N1 (flakono adapteris, švirkštas ir inje
EU/1/20/1482/001
CP
17-12-2020
REKAMBYS 900 MG pr susp for inj
N1 (flakono adapteris, švirkštas ir inje
EU/1/20/1482/002
CP
17-12-2020
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Malta (0)
No result.
Netherlands (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT, 25MG fc tabs
-
Rx
-
J05AG05
REKAMBYS 300 MG/ML pr susp for inj
-
Rx
-
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT, 25MG fc tabs
  EU/1/11/736
-
28-11-2011
REKAMBYS 300 MG/ML pr susp for inj
EU/1/20/1482
-
04-02-2021
Product
Pack
SPC
PIL
Company
EDURANT, 25MG fc tabs
REKAMBYS 300 MG/ML pr susp for inj
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Norway (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT 25 MG fc tabs
30
-
Rx
oral
J05AG05
REKAMBYS DEP 900 MG Depotinjeksjonsvæske, suspensjon
900
-
Rx
im
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT 25 MG fc tabs
30
01-03-2012
REKAMBYS DEP 900 MG Depotinjeksjonsvæske, suspensjon
900
01-04-2021
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Poland (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT 25 MG fc tabs
30 tabs
-
Rx
-
J05AG05
REKAMBYS 600 MG pr susp for inj
1 vial + zestaw
-
-
J05AG05
REKAMBYS 900 MG pr susp for inj
1 vial + zestaw
-
-
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT 25 MG fc tabs
30 tabs
CP
REKAMBYS 600 MG pr susp for inj
1 vial + zestaw
CP
REKAMBYS 900 MG pr susp for inj
1 vial + zestaw
CP
Product
Pack
SPC
PIL
Company
EDURANT 25 MG fc tabs
30 tabs
REKAMBYS 600 MG pr susp for inj
1 vial + zestaw
REKAMBYS 900 MG pr susp for inj
1 vial + zestaw
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Romania (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT fc tabs
un flacon din PEÎD x 30 tabs filmate
-
PR
-
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT fc tabs
un flacon din PEÎD x 30 tabs filmate
-
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Slovenia (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT 25 MG fc tabs
30 tabs plastenki
N
Rx
oral
J05AG05
REKAMBYS 600 MG S PODALJšANIM SPROščANJEM ZA INJICIRANJE raztopina s podaljšanim sproščanjem za injiciranje
1 vialo
-
Rx
im
J05AG05
REKAMBYS 900 MG S PODALJšANIM SPROščANJEM ZA INJICIRANJE raztopina s podaljšanim sproščanjem za injiciranje
1 vialo
-
Rx
im
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT 25 MG fc tabs
30 tabs plastenki
EU/1/11/736/001
CP
23-04-2012
REKAMBYS 600 MG S PODALJšANIM SPROščANJEM ZA INJICIRANJE raztopina s podaljšanim sproščanjem za injiciranje
1 vialo
1024-64/2020-4
CP
23-12-2020
REKAMBYS 900 MG S PODALJšANIM SPROščANJEM ZA INJICIRANJE raztopina s podaljšanim sproščanjem za injiciranje
1 vialo
1024-64/2020-4
CP
23-12-2020
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
EDURANT 25 MG fc tabs
30 tabs plastenki
210,07
REKAMBYS 600 MG S PODALJšANIM SPROščANJEM ZA INJICIRANJE raztopina s podaljšanim sproščanjem za injiciranje
1 vialo
REKAMBYS 900 MG S PODALJšANIM SPROščANJEM ZA INJICIRANJE raztopina s podaljšanim sproščanjem za injiciranje
1 vialo
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Spain (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT 25 MG fc tabs
30 tabs
Y
Rx
oral
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT 25 MG fc tabs
30 tabs
11736001
13-01-2012
Product
Pack
SPC
PIL
Company
EDURANT 25 MG fc tabs
30 tabs
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Sweden (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT 25 MG fc tabs
Rx
-
J05AG05
REKAMBYS 600 MG pr susp for inj
Rx
-
J05AG05
REKAMBYS 900 MG pr susp for inj
Rx
-
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT 25 MG fc tabs
CP
28-11-2011
REKAMBYS 600 MG pr susp for inj
CP
17-12-2020
REKAMBYS 900 MG pr susp for inj
CP
17-12-2020
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Switzerland (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EDURANT fc tabs
-
A
-
J05AG05
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EDURANT fc tabs
61548 1
Hauptzulassung
26-02-2013
25-02-2023
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.